Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML) View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-01

AUTHORS

Bernard Tawfik, Sarunas Sliesoraitis, Susan Lyerly, Heidi D. Klepin, Julia Lawrence, Scott Isom, Leslie R. Ellis, Megan Manuel, Sarah Dralle, Dmitriy Berenzon, Bayard L. Powell, Timothy Pardee

ABSTRACT

The hypomethylating agents (HAs), azacitidine and decitabine, have emerged as an alternative to initial and salvage therapy in patients with acute myeloid leukemia (AML). Little is known about how AML responds to hypomethylating agents after standard therapy, and the activity of these agents in a real-world setting is not well studied. We retrospectively examined data for 75 consecutive AML patients at Wake Forest from 2002 to 2011 treated with HAs either as first-line (n = 34), salvage (n = 28), or consolidation (n = 13) therapy. We collected data on age, gender, race, Charlson comorbidity index (CCI), cytogenetics, type of treatment, complete remission (CR), complete remission with incomplete count recovery (CRi), and survival. Statistical analysis was performed using Kaplan-Meier estimates and Cox proportional hazards models. Frontline response rate (CR + CRi) was 26.5 %, and median overall survival (OS) was 3.4 months (95 % CI 1.3-7.4), with 18 % alive at 1 year. In the salvage cohort, the response rate was significantly lower compared to frontline (3.6 versus 26.5 %, p = 0.017). Despite the reduced response, OS from time of HA treatment was longer than frontline at 8.2 months (CI 4.8-10.3). In the consolidation cohort, OS was 13.8 months (CI 8.0-21.6) with one patient in remission more than 30 months from diagnosis. These data suggest that prior cytotoxic therapy decreases marrow response rates to HAs but not survival. Furthermore, use of hypomethylating agents for consolidation resulted in a median overall survival over 1 year in a cohort of older patients. This suggests that hypomethylating agents have activity in all phases of AML treatment. More... »

PAGES

47-55

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-013-1940-9

DOI

http://dx.doi.org/10.1007/s00277-013-1940-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050456081

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24149914


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Azacitidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Comorbidity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Consolidation Chemotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA (Cytosine-5-)-Methyltransferases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Damage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Methylation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Evaluation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salvage Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tawfik", 
        "givenName": "Bernard", 
        "id": "sg:person.0645742454.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645742454.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sliesoraitis", 
        "givenName": "Sarunas", 
        "id": "sg:person.0721516137.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721516137.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section on Hematology and Oncology, Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lyerly", 
        "givenName": "Susan", 
        "id": "sg:person.0762171054.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762171054.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section on Hematology and Oncology, Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Klepin", 
        "givenName": "Heidi D.", 
        "id": "sg:person.01047614615.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047614615.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section on Hematology and Oncology, Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lawrence", 
        "givenName": "Julia", 
        "id": "sg:person.01354175611.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354175611.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA", 
            "Section on Hematology and Oncology, Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Isom", 
        "givenName": "Scott", 
        "id": "sg:person.01236071332.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236071332.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section on Hematology and Oncology, Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ellis", 
        "givenName": "Leslie R.", 
        "id": "sg:person.01063440676.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063440676.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section on Hematology and Oncology, Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Manuel", 
        "givenName": "Megan", 
        "id": "sg:person.01260761254.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260761254.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section on Hematology and Oncology, Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dralle", 
        "givenName": "Sarah", 
        "id": "sg:person.01327074454.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327074454.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section on Hematology and Oncology, Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berenzon", 
        "givenName": "Dmitriy", 
        "id": "sg:person.0614664642.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614664642.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section on Hematology and Oncology, Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Powell", 
        "givenName": "Bayard L.", 
        "id": "sg:person.01145714620.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145714620.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wake Forest Baptist Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412860.9", 
          "name": [
            "Section on Hematology and Oncology, Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA", 
            "Cancer Biology, Comprehensive Cancer Center of Wake Forest University, Medical Center Blvd, 27157, Winston-Salem, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pardee", 
        "givenName": "Timothy", 
        "id": "sg:person.0607111065.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607111065.98"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0268-960x(98)90012-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000403299"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/moh.0b013e32835dd99d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002596389"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ajh.21857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002925093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ajh.21857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002925093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.1002650107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004089419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood.v98.5.1302", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006197523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(19971201)80:11+<2205::aid-cncr7>3.0.co;2-g", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007758820"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hon.986", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010302559"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.162.14.1597", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010636860"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2005-01-0178", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014214168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0895-4356(94)90129-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020595986"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ajh.23464", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022579419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2005-11-4354", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025102974"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.22779", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026267271"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2005-09-3724", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026569999"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199410063311402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026923022"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2011.9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030865498", 
          "https://doi.org/10.1038/leu.2011.9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.22496", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032101464"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/caac.20121", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032384183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2010.036921", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032877411"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-01-267302", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036440037"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.leukres.2013.03.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037362030"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.8329", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037462198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-11-382226", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039037609"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-07-235358", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042177075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26354", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043164544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.9178", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044032367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-03-413898", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049230850"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/asheducation-2007.1.420", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049507627"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-005-1037-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050396865", 
          "https://doi.org/10.1007/s00277-005-1037-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00277-005-1037-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050396865", 
          "https://doi.org/10.1007/s00277-005-1037-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.38.9429", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052466310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074737871", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1988.6.4.583", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079660324"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083183387", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-01", 
    "datePublishedReg": "2014-01-01", 
    "description": "The hypomethylating agents (HAs), azacitidine and decitabine, have emerged as an alternative to initial and salvage therapy in patients with acute myeloid leukemia (AML). Little is known about how AML responds to hypomethylating agents after standard therapy, and the activity of these agents in a real-world setting is not well studied. We retrospectively examined data for 75 consecutive AML patients at Wake Forest from 2002 to 2011 treated with HAs either as first-line (n\u2009=\u200934), salvage (n\u2009=\u200928), or consolidation (n\u2009=\u200913) therapy. We collected data on age, gender, race, Charlson comorbidity index (CCI), cytogenetics, type of treatment, complete remission (CR), complete remission with incomplete count recovery (CRi), and survival. Statistical analysis was performed using Kaplan-Meier estimates and Cox proportional hazards models. Frontline response rate (CR + CRi) was 26.5 %, and median overall survival (OS) was 3.4 months (95 % CI 1.3-7.4), with 18 % alive at 1 year. In the salvage cohort, the response rate was significantly lower compared to frontline (3.6 versus 26.5 %, p\u2009=\u20090.017). Despite the reduced response, OS from time of HA treatment was longer than frontline at 8.2 months (CI 4.8-10.3). In the consolidation cohort, OS was 13.8 months (CI 8.0-21.6) with one patient in remission more than 30 months from diagnosis. These data suggest that prior cytotoxic therapy decreases marrow response rates to HAs but not survival. Furthermore, use of hypomethylating agents for consolidation resulted in a median overall survival over 1 year in a cohort of older patients. This suggests that hypomethylating agents have activity in all phases of AML treatment.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00277-013-1940-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2417933", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438796", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2411288", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1018247", 
        "issn": [
          "1269-3286", 
          "1279-8509"
        ], 
        "name": "Annals of Hematology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "93"
      }
    ], 
    "name": "Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML)", 
    "pagination": "47-55", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f05afb8f580867f1609d1a4df91d947c00d9e669c3fba4891e54737ef9d9c31a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24149914"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9107334"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-013-1940-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050456081"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-013-1940-9", 
      "https://app.dimensions.ai/details/publication/pub.1050456081"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:53", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000491.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00277-013-1940-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-013-1940-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-013-1940-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-013-1940-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-013-1940-9'


 

This table displays all metadata directly associated to this object as RDF triples.

345 TRIPLES      21 PREDICATES      85 URIs      44 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-013-1940-9 schema:about N0c485336fd7c42b88f57f4fa18da20cb
2 N0f26e3867e82426a89e2e16f47c35dc4
3 N1dd482e6be3f4a19a1786b1dcfd88995
4 N3bc363dc706b41159cd017f63976e180
5 N3e6927104833430c9bb2e33d67928c04
6 N411af9cb0fb24ae8af0eb38168adabbe
7 N42f9ee8d945b42e3910a6ad4f75b1e84
8 N4d35359a3e244c08aa73e941f9ea1587
9 N5d7a03f987284f7081c9977d3b4534bc
10 N5f7181e6c8ef4198b9e2c8e083346a89
11 N61a44a4bf0dc4569a1913af245a76e3d
12 N66bd2490a2254d11ad8e1d5264f92408
13 N6e0acf346ad44f7c86c8e5de6c65fd22
14 N7df5031e5e4f46499827070411a79d48
15 N825f103d16f640a7ae647bf9c8a13f31
16 N89361329558b486b9aef755d9c26ec10
17 Na36f25d73ca2436cb671b19939204710
18 Na9a1dfd659bd4bdb8b4c54ac14a8ee0d
19 Ne50f284839524eb19c833085c00d3ce3
20 Ne5c9f32ae9c64a1da40d92cfbcd478e6
21 Ne8af3292720445f68e3e04c99e2fa317
22 Ne949711e369a46c7aa9feaec177a47a2
23 Nf7de076230d8428792b1d7fdb307f97d
24 anzsrc-for:11
25 anzsrc-for:1112
26 schema:author Nd93c0e97e06340e6a876316cce8ad158
27 schema:citation sg:pub.10.1007/s00277-005-1037-1
28 sg:pub.10.1038/leu.2011.9
29 https://app.dimensions.ai/details/publication/pub.1074737871
30 https://app.dimensions.ai/details/publication/pub.1083183387
31 https://doi.org/10.1001/archinte.162.14.1597
32 https://doi.org/10.1002/(sici)1097-0142(19971201)80:11+<2205::aid-cncr7>3.0.co;2-g
33 https://doi.org/10.1002/ajh.21857
34 https://doi.org/10.1002/ajh.23464
35 https://doi.org/10.1002/cncr.22496
36 https://doi.org/10.1002/cncr.22779
37 https://doi.org/10.1002/cncr.26354
38 https://doi.org/10.1002/hon.986
39 https://doi.org/10.1016/0895-4356(94)90129-5
40 https://doi.org/10.1016/j.leukres.2013.03.022
41 https://doi.org/10.1016/s0268-960x(98)90012-1
42 https://doi.org/10.1056/nejm199410063311402
43 https://doi.org/10.1073/pnas.1002650107
44 https://doi.org/10.1097/moh.0b013e32835dd99d
45 https://doi.org/10.1182/asheducation-2007.1.420
46 https://doi.org/10.1182/blood-2005-01-0178
47 https://doi.org/10.1182/blood-2005-09-3724
48 https://doi.org/10.1182/blood-2005-11-4354
49 https://doi.org/10.1182/blood-2009-07-235358
50 https://doi.org/10.1182/blood-2010-01-267302
51 https://doi.org/10.1182/blood-2011-11-382226
52 https://doi.org/10.1182/blood-2012-03-413898
53 https://doi.org/10.1182/blood.v98.5.1302
54 https://doi.org/10.1200/jco.1988.6.4.583
55 https://doi.org/10.1200/jco.2009.23.8329
56 https://doi.org/10.1200/jco.2009.23.9178
57 https://doi.org/10.1200/jco.2011.38.9429
58 https://doi.org/10.3322/caac.20121
59 https://doi.org/10.3324/haematol.2010.036921
60 schema:datePublished 2014-01
61 schema:datePublishedReg 2014-01-01
62 schema:description The hypomethylating agents (HAs), azacitidine and decitabine, have emerged as an alternative to initial and salvage therapy in patients with acute myeloid leukemia (AML). Little is known about how AML responds to hypomethylating agents after standard therapy, and the activity of these agents in a real-world setting is not well studied. We retrospectively examined data for 75 consecutive AML patients at Wake Forest from 2002 to 2011 treated with HAs either as first-line (n = 34), salvage (n = 28), or consolidation (n = 13) therapy. We collected data on age, gender, race, Charlson comorbidity index (CCI), cytogenetics, type of treatment, complete remission (CR), complete remission with incomplete count recovery (CRi), and survival. Statistical analysis was performed using Kaplan-Meier estimates and Cox proportional hazards models. Frontline response rate (CR + CRi) was 26.5 %, and median overall survival (OS) was 3.4 months (95 % CI 1.3-7.4), with 18 % alive at 1 year. In the salvage cohort, the response rate was significantly lower compared to frontline (3.6 versus 26.5 %, p = 0.017). Despite the reduced response, OS from time of HA treatment was longer than frontline at 8.2 months (CI 4.8-10.3). In the consolidation cohort, OS was 13.8 months (CI 8.0-21.6) with one patient in remission more than 30 months from diagnosis. These data suggest that prior cytotoxic therapy decreases marrow response rates to HAs but not survival. Furthermore, use of hypomethylating agents for consolidation resulted in a median overall survival over 1 year in a cohort of older patients. This suggests that hypomethylating agents have activity in all phases of AML treatment.
63 schema:genre research_article
64 schema:inLanguage en
65 schema:isAccessibleForFree true
66 schema:isPartOf N88234137721e4f1492512973747beefb
67 N9adf44949243439cb1504cbc796bed0f
68 sg:journal.1018247
69 schema:name Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML)
70 schema:pagination 47-55
71 schema:productId N395242d540ec4e6ca98845236944a94c
72 N71ce70965d8541cdb4a767953268013b
73 N7471f8bebd684073a94ff820a4042140
74 Nba6f009a11bd4a26b0550f38523f6cef
75 Ndabf3017fad6428fbb30419bb8072967
76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050456081
77 https://doi.org/10.1007/s00277-013-1940-9
78 schema:sdDatePublished 2019-04-10T19:53
79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
80 schema:sdPublisher Nf4abe7a943bb473fa27aededa66513bd
81 schema:url http://link.springer.com/10.1007/s00277-013-1940-9
82 sgo:license sg:explorer/license/
83 sgo:sdDataset articles
84 rdf:type schema:ScholarlyArticle
85 N01dc934e5a6b4b698b9b170b86cc4bae rdf:first sg:person.01236071332.46
86 rdf:rest Nb5158ac938334485b00c679a6fdaae0e
87 N0c485336fd7c42b88f57f4fa18da20cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Proportional Hazards Models
89 rdf:type schema:DefinedTerm
90 N0f26e3867e82426a89e2e16f47c35dc4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Antineoplastic Combined Chemotherapy Protocols
92 rdf:type schema:DefinedTerm
93 N12ce6968ed92449fb125dbedb9f565a3 rdf:first sg:person.01145714620.74
94 rdf:rest Nababcb5e1fa34b4fa0d57ee9ee836b63
95 N1dd482e6be3f4a19a1786b1dcfd88995 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Survival Rate
97 rdf:type schema:DefinedTerm
98 N1fd8a08479ae4d6584219ba9c1982e1a rdf:first sg:person.0721516137.53
99 rdf:rest N4a94729f45cd453287944bd9672327fa
100 N395242d540ec4e6ca98845236944a94c schema:name nlm_unique_id
101 schema:value 9107334
102 rdf:type schema:PropertyValue
103 N3bc363dc706b41159cd017f63976e180 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name DNA Damage
105 rdf:type schema:DefinedTerm
106 N3e6927104833430c9bb2e33d67928c04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Female
108 rdf:type schema:DefinedTerm
109 N411af9cb0fb24ae8af0eb38168adabbe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Middle Aged
111 rdf:type schema:DefinedTerm
112 N42f9ee8d945b42e3910a6ad4f75b1e84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Leukemia, Myeloid, Acute
114 rdf:type schema:DefinedTerm
115 N484a07c58efa46709331ee614219c519 rdf:first sg:person.01047614615.33
116 rdf:rest N647dd28d4b7e4797a08d51159c1b1ebe
117 N4a94729f45cd453287944bd9672327fa rdf:first sg:person.0762171054.28
118 rdf:rest N484a07c58efa46709331ee614219c519
119 N4d35359a3e244c08aa73e941f9ea1587 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Retrospective Studies
121 rdf:type schema:DefinedTerm
122 N5d7a03f987284f7081c9977d3b4534bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Remission Induction
124 rdf:type schema:DefinedTerm
125 N5f7181e6c8ef4198b9e2c8e083346a89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Humans
127 rdf:type schema:DefinedTerm
128 N61a44a4bf0dc4569a1913af245a76e3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Male
130 rdf:type schema:DefinedTerm
131 N647dd28d4b7e4797a08d51159c1b1ebe rdf:first sg:person.01354175611.74
132 rdf:rest N01dc934e5a6b4b698b9b170b86cc4bae
133 N66bd2490a2254d11ad8e1d5264f92408 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Age Factors
135 rdf:type schema:DefinedTerm
136 N6e0acf346ad44f7c86c8e5de6c65fd22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Aged
138 rdf:type schema:DefinedTerm
139 N71ce70965d8541cdb4a767953268013b schema:name doi
140 schema:value 10.1007/s00277-013-1940-9
141 rdf:type schema:PropertyValue
142 N7471f8bebd684073a94ff820a4042140 schema:name dimensions_id
143 schema:value pub.1050456081
144 rdf:type schema:PropertyValue
145 N7df5031e5e4f46499827070411a79d48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Drug Evaluation
147 rdf:type schema:DefinedTerm
148 N825f103d16f640a7ae647bf9c8a13f31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name DNA, Neoplasm
150 rdf:type schema:DefinedTerm
151 N88234137721e4f1492512973747beefb schema:issueNumber 1
152 rdf:type schema:PublicationIssue
153 N89361329558b486b9aef755d9c26ec10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Neoplasm Proteins
155 rdf:type schema:DefinedTerm
156 N9adf44949243439cb1504cbc796bed0f schema:volumeNumber 93
157 rdf:type schema:PublicationVolume
158 Na36f25d73ca2436cb671b19939204710 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name DNA (Cytosine-5-)-Methyltransferases
160 rdf:type schema:DefinedTerm
161 Na9a1dfd659bd4bdb8b4c54ac14a8ee0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Kaplan-Meier Estimate
163 rdf:type schema:DefinedTerm
164 Nababcb5e1fa34b4fa0d57ee9ee836b63 rdf:first sg:person.0607111065.98
165 rdf:rest rdf:nil
166 Nb5158ac938334485b00c679a6fdaae0e rdf:first sg:person.01063440676.04
167 rdf:rest Ne00a752438ee437f9ba68cabb3bfcc96
168 Nba6f009a11bd4a26b0550f38523f6cef schema:name pubmed_id
169 schema:value 24149914
170 rdf:type schema:PropertyValue
171 Nc8d78ce4ea7f4aaa830c25f4bb76b32c rdf:first sg:person.01327074454.51
172 rdf:rest Ne948a821199d408e8de98f95f4b0db57
173 Nd93c0e97e06340e6a876316cce8ad158 rdf:first sg:person.0645742454.19
174 rdf:rest N1fd8a08479ae4d6584219ba9c1982e1a
175 Ndabf3017fad6428fbb30419bb8072967 schema:name readcube_id
176 schema:value f05afb8f580867f1609d1a4df91d947c00d9e669c3fba4891e54737ef9d9c31a
177 rdf:type schema:PropertyValue
178 Ne00a752438ee437f9ba68cabb3bfcc96 rdf:first sg:person.01260761254.81
179 rdf:rest Nc8d78ce4ea7f4aaa830c25f4bb76b32c
180 Ne50f284839524eb19c833085c00d3ce3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Azacitidine
182 rdf:type schema:DefinedTerm
183 Ne5c9f32ae9c64a1da40d92cfbcd478e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Comorbidity
185 rdf:type schema:DefinedTerm
186 Ne8af3292720445f68e3e04c99e2fa317 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name DNA Methylation
188 rdf:type schema:DefinedTerm
189 Ne948a821199d408e8de98f95f4b0db57 rdf:first sg:person.0614664642.52
190 rdf:rest N12ce6968ed92449fb125dbedb9f565a3
191 Ne949711e369a46c7aa9feaec177a47a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Consolidation Chemotherapy
193 rdf:type schema:DefinedTerm
194 Nf4abe7a943bb473fa27aededa66513bd schema:name Springer Nature - SN SciGraph project
195 rdf:type schema:Organization
196 Nf7de076230d8428792b1d7fdb307f97d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Salvage Therapy
198 rdf:type schema:DefinedTerm
199 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
200 schema:name Medical and Health Sciences
201 rdf:type schema:DefinedTerm
202 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
203 schema:name Oncology and Carcinogenesis
204 rdf:type schema:DefinedTerm
205 sg:grant.2411288 http://pending.schema.org/fundedItem sg:pub.10.1007/s00277-013-1940-9
206 rdf:type schema:MonetaryGrant
207 sg:grant.2417933 http://pending.schema.org/fundedItem sg:pub.10.1007/s00277-013-1940-9
208 rdf:type schema:MonetaryGrant
209 sg:grant.2438796 http://pending.schema.org/fundedItem sg:pub.10.1007/s00277-013-1940-9
210 rdf:type schema:MonetaryGrant
211 sg:journal.1018247 schema:issn 1269-3286
212 1279-8509
213 schema:name Annals of Hematology
214 rdf:type schema:Periodical
215 sg:person.01047614615.33 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
216 schema:familyName Klepin
217 schema:givenName Heidi D.
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047614615.33
219 rdf:type schema:Person
220 sg:person.01063440676.04 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
221 schema:familyName Ellis
222 schema:givenName Leslie R.
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063440676.04
224 rdf:type schema:Person
225 sg:person.01145714620.74 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
226 schema:familyName Powell
227 schema:givenName Bayard L.
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145714620.74
229 rdf:type schema:Person
230 sg:person.01236071332.46 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
231 schema:familyName Isom
232 schema:givenName Scott
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236071332.46
234 rdf:type schema:Person
235 sg:person.01260761254.81 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
236 schema:familyName Manuel
237 schema:givenName Megan
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260761254.81
239 rdf:type schema:Person
240 sg:person.01327074454.51 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
241 schema:familyName Dralle
242 schema:givenName Sarah
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327074454.51
244 rdf:type schema:Person
245 sg:person.01354175611.74 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
246 schema:familyName Lawrence
247 schema:givenName Julia
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354175611.74
249 rdf:type schema:Person
250 sg:person.0607111065.98 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
251 schema:familyName Pardee
252 schema:givenName Timothy
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607111065.98
254 rdf:type schema:Person
255 sg:person.0614664642.52 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
256 schema:familyName Berenzon
257 schema:givenName Dmitriy
258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614664642.52
259 rdf:type schema:Person
260 sg:person.0645742454.19 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
261 schema:familyName Tawfik
262 schema:givenName Bernard
263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645742454.19
264 rdf:type schema:Person
265 sg:person.0721516137.53 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
266 schema:familyName Sliesoraitis
267 schema:givenName Sarunas
268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721516137.53
269 rdf:type schema:Person
270 sg:person.0762171054.28 schema:affiliation https://www.grid.ac/institutes/grid.412860.9
271 schema:familyName Lyerly
272 schema:givenName Susan
273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762171054.28
274 rdf:type schema:Person
275 sg:pub.10.1007/s00277-005-1037-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050396865
276 https://doi.org/10.1007/s00277-005-1037-1
277 rdf:type schema:CreativeWork
278 sg:pub.10.1038/leu.2011.9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030865498
279 https://doi.org/10.1038/leu.2011.9
280 rdf:type schema:CreativeWork
281 https://app.dimensions.ai/details/publication/pub.1074737871 schema:CreativeWork
282 https://app.dimensions.ai/details/publication/pub.1083183387 schema:CreativeWork
283 https://doi.org/10.1001/archinte.162.14.1597 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010636860
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1002/(sici)1097-0142(19971201)80:11+<2205::aid-cncr7>3.0.co;2-g schema:sameAs https://app.dimensions.ai/details/publication/pub.1007758820
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1002/ajh.21857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002925093
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1002/ajh.23464 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022579419
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1002/cncr.22496 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032101464
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1002/cncr.22779 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026267271
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1002/cncr.26354 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043164544
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1002/hon.986 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010302559
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1016/0895-4356(94)90129-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020595986
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1016/j.leukres.2013.03.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037362030
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1016/s0268-960x(98)90012-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000403299
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1056/nejm199410063311402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026923022
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1073/pnas.1002650107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004089419
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1097/moh.0b013e32835dd99d schema:sameAs https://app.dimensions.ai/details/publication/pub.1002596389
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1182/asheducation-2007.1.420 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049507627
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1182/blood-2005-01-0178 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014214168
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1182/blood-2005-09-3724 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026569999
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1182/blood-2005-11-4354 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025102974
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1182/blood-2009-07-235358 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042177075
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1182/blood-2010-01-267302 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036440037
322 rdf:type schema:CreativeWork
323 https://doi.org/10.1182/blood-2011-11-382226 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039037609
324 rdf:type schema:CreativeWork
325 https://doi.org/10.1182/blood-2012-03-413898 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049230850
326 rdf:type schema:CreativeWork
327 https://doi.org/10.1182/blood.v98.5.1302 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006197523
328 rdf:type schema:CreativeWork
329 https://doi.org/10.1200/jco.1988.6.4.583 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079660324
330 rdf:type schema:CreativeWork
331 https://doi.org/10.1200/jco.2009.23.8329 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037462198
332 rdf:type schema:CreativeWork
333 https://doi.org/10.1200/jco.2009.23.9178 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044032367
334 rdf:type schema:CreativeWork
335 https://doi.org/10.1200/jco.2011.38.9429 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052466310
336 rdf:type schema:CreativeWork
337 https://doi.org/10.3322/caac.20121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032384183
338 rdf:type schema:CreativeWork
339 https://doi.org/10.3324/haematol.2010.036921 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032877411
340 rdf:type schema:CreativeWork
341 https://www.grid.ac/institutes/grid.412860.9 schema:alternateName Wake Forest Baptist Medical Center
342 schema:name Cancer Biology, Comprehensive Cancer Center of Wake Forest University, Medical Center Blvd, 27157, Winston-Salem, NC, USA
343 Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA
344 Section on Hematology and Oncology, Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA
345 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...